Company Filing History:
4 out of 281 
2 out of 2,560 
Years Active: 1999-2002
Title: The Innovations of Eiichi Shirasawa
Introduction
Eiichi Shirasawa is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating glaucoma. With a total of 4 patents to his name, Shirasawa's work has had a meaningful impact on ocular health.
Latest Patents
Shirasawa's latest patents include innovative compounds such as 1,2-diphenyl-2-propen-1-one derivatives. This invention provides compounds represented by a specific formula that lower intraocular pressure by inducing morphological changes in trabecular meshwork cells. The formula includes various substituents, allowing for a range of chemical modifications. Another significant patent involves vinylbenzene derivatives, which are useful as therapeutic agents for glaucoma. These compounds also follow a general formula that enhances their therapeutic potential.
Career Highlights
Throughout his career, Shirasawa has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Santen Pharmaceutical Co., Ltd. and Asahi Glass Company, Limited. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Shirasawa has collaborated with esteemed colleagues such as Masaaki Kageyama and Tadashi Nakajima. These partnerships have fostered a collaborative environment that has been essential for the development of his patented inventions.
Conclusion
Eiichi Shirasawa's contributions to the field of pharmaceuticals, particularly in glaucoma treatment, highlight his innovative spirit and dedication to improving ocular health. His patents reflect a commitment to advancing medical science through research and collaboration.